ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,789,000 | -19.9% | 258,214 | -15.4% | 0.24% | -19.7% |
| Q2 2022 | $3,480,000 | -23.8% | 305,253 | -39.1% | 0.30% | -17.6% |
| Q1 2022 | $4,566,000 | -69.3% | 501,219 | -49.7% | 0.36% | -62.3% |
| Q4 2021 | $14,862,000 | -36.8% | 996,116 | +8.9% | 0.95% | -35.0% |
| Q3 2021 | $23,500,000 | +16.5% | 914,416 | +18.2% | 1.46% | +42.6% |
| Q2 2021 | $20,174,000 | +6.5% | 773,562 | +44.1% | 1.02% | -18.6% |
| Q1 2021 | $18,947,000 | – | 536,738 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |